CAPA Effectiveness in the Pharma Industry Repeated Environmental Monitoring Excursions Scenario: During routine environmental monitoring of a Grade C manufacturing area, repeated excursions in microbial counts are observed at a specific monitoring location. Initial Observation – Over three months: Multiple microbial excursions occurred at the same location. Initial investigations focused primarily on cleaning and operator practices. … Read more
Pharmaceutical Change Control: GMP Process, Risk Assessment & Implementation Pharmaceutical Change: HVAC and Environmental Control 1. Proposed Pharmaceutical Change: Replace and upgrade an existing HVAC system serving a Grade C manufacturing area to improve temperature, relative humidity, pressure differential, air-change performance, and overall environmental control. Reason for This Pharmaceutical Change: The existing HVAC system is … Read more
Quality by Design (QbD) Framework for tablet manufacturing, covering Critical Quality Attributes (CQAs), Critical Process Parameters (CPPs), their relationship, and a practical risk assessment. 1. Tablet Manufacturing – Critical Quality Attributes (CQAs) CQAs are physical, chemical, microbiological, or performance characteristics that must remain within an appropriate limit/range to ensure the finished tablet meets its intended … Read more
EMPLOYEE JOINING & INDUCTION 1. PURPOSE To establish a controlled and consistent procedure for the joining, onboarding, orientation, induction, qualification, and initial training of newly hired employees so that each employee: Is formally and accurately onboarded; Understands the organization’s expectations, responsibilities, and workplace requirements; Receives the information and training necessary to perform assigned duties; Understands … Read more
RECRUITMENT & SELECTION POLICY 1. PURPOSE The purpose of this policy is to establish a fair, consistent, documented, competency-based, and legally compliant recruitment and selection process for hiring qualified personnel. The policy ensures that the organization recruits individuals whose education, training, experience, technical knowledge, skills, and competencies are appropriate for their assigned responsibilities. For pharmaceutical … Read more
HR (HUMAN RESOURCES) POLICIES & STANDARD OPERATING PROCEDURES 1. Purpose The purpose of this HR Policy and SOP framework is to establish a consistent, transparent, compliant, and documented system for managing employees throughout their employment lifecycle. The system shall ensure that personnel are: Qualified for their assigned responsibilities. Adequately trained before performing GMP-related activities. Aware of … Read more
Quality Risk Management for New Products, Processes, Equipment, Facilities, Technology Transfer and Scale-Up Introducing a new pharmaceutical product, manufacturing process, equipment, facility modification, technology transfer, scale-up activity, or process change can create significant quality risks. A change that appears technically simple may affect: Critical Quality Attributes (CQAs) Critical Process Parameters (CPPs) Material attributes Process capability … Read more
Pharmaceutical eQMS & Digitalization FDA Compliance: A Practical Guide for FDA-Regulated Companies Digital transformation is changing how pharmaceutical companies manage quality, compliance, documentation, and operational risk. For many years, pharmaceutical Quality Assurance departments relied heavily on paper-based systems, spreadsheets, email approvals, and manually maintained quality records. While these approaches can support basic operations, they can … Read more
Continual Improvement of the Pharmaceutical Quality System: A Practical FDA, ICH & PIC/S Framework A pharmaceutical quality system should do more than demonstrate compliance. It should enable an organization to identify emerging risks, understand process performance, learn from quality events, and continuously improve its operations. For pharmaceutical manufacturers supplying the United States, continual improvement should … Read more
EYE/EAR DROPS S.no GENERIC NAME COMPOSTION REF . CLAIM STRENGTH 1. Atropine Sulphate Ophthalmic Solution IP Composition: Atropine Sulphate IP 1%, w/v Phenyl Mercuric Nitrate (As Preservative) IP 0.001% w/v Sterile Aqueous Base q.s 2. Atropine sulphate ophthalmic solution IP Composition: Atropine sulphate IP 0.01%&0.05% w/v StabilisedOxychloro Complex (As Preservative) 0.005% v/v Sterile Aqueous … Read more